Ray Dalio Lantheus Holdings, Inc. Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 76,370 shares of LNTH stock, worth $6.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

76,370

Previous 71,671 6.56%

Holding current value

$6.25 Million

Previous $4.44 Million 6.98%

% of portfolio

0.02%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $239,977 - $320,753	4,699 Added 6.56%	76,370 $4.75 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $431,066 - $603,881	-7,753 Reduced 9.76%	71,671 $4.44 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $369,816 - $556,842	6,136 Added 8.37%	79,424 $5.52 Million
Q2 2023 Aug 11, 2023	SELL	$82.41 - $99.65 $680,129 - $822,411	-8,253 Reduced 10.12%	73,288 $6.15 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $90,744 - $157,434	1,900 Added 2.39%	81,541 $6.73 Million

Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $1.32 Million - $2.11 Million	-27,115 Reduced 25.4%	79,641 $4.06 Million
Q3 2022 Nov 10, 2022	BUY	$61.42 - $86.29 $4,422 - $6,212	72 Added 0.07%	106,756 $7.51 Million
Q2 2022 Aug 11, 2022	BUY	$55.54 - $72.65 $594,333 - $777,427	10,701 Added 11.15%	106,684 $7.04 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $552,418 - $1.29 Million	22,752 Added 31.07%	95,983 $5.31 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $170,965 - $230,887	7,585 Added 11.55%	73,231 $2.12 Million
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $104,310 - $123,079	-4,305 Reduced 6.15%	65,646 $1.69 Million
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $1.36 Million - $1.93 Million	69,951 New	69,951 $1.93 Million

Others Institutions Holding LNTH

# of Institutions

444

Shares Held

65.1M

Call Options Held

1.47M

Put Options Held

771K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account